High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer

The purpose of the study was to compare breast-conserving therapy (BCT) and mastectomy (M) in BRCA1/2 mutation carriers. Women with invasive breast cancer and a pathogenic mutation in BRCA1 or BRCA2 were included in the study (n = 162). Patients treated with BCT (n = 45) were compared with patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsson, Martin P., Hartman, Linda, Kristoffersson, Ulf, Johannsson, Oskar T., Borg, Åke, Henriksson, Karin, Lanke, Elsa, Olsson, Håkan, Loman, Niklas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174291/
https://www.ncbi.nlm.nih.gov/pubmed/25187270
http://dx.doi.org/10.1007/s10549-014-3115-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174291/
https://www.ncbi.nlm.nih.gov/pubmed/25187270
http://dx.doi.org/10.1007/s10549-014-3115-3

Ejemplares similares